LGC Capital Shares Australian Market Update

Cannabis Investing News

LGC Capital announced that Little Green Pharma received their final permits from the Australian Government enabling them to move to their first commercial production of medical cannabis.

LGC Capital (TSXV:LG) announced that Little Green Pharma received their final permits from the Australian Government enabling them to move to their first commercial production of medical cannabis.
As quoted in the press release:

Little Green Pharma have also advised LGC that they plan to start growing within weeks.

John McMullen, LGC Capital’s CEO, comment; “Little Green Pharma have advised us that they have now received their final permits from the Australian Government to commence commercial production of Medical Cannabis for the Australian Market and they plan to be growing within weeks. Not only are Little Green Pharma one of the few licensed companies in Australia in the sector, but now they are also one of the very few companies permitted to grow Medical Cannabis for commercial production.

Click here to read the full press release.

Source: www.newswire.ca

australia lgc lgc capital us Cannabis Investing